, released company from certain operating expenses. • Regarding to costs control in raw material, promotional and selling expenses and administration expenses, company delivered significant improvement in

Performance The Company reported Revenues from hospital operations of Baht 413.43 million, a 46.92% improvement year-over-year from Baht 281.40 million in 6M18. This was mostly due to an increase in revenues

asset by 5 MB and 1 MB for the non-current asset  Liabilities As of March 31, 2018, the Company and its subsidiaries have a total liability of 412 MB decreased 30 MB from December 31, 2017 and having

asset at 5.3 MB and 1.2 MB for the non-current asset  Liabilities As of June 30, 2018, the Company and its subsidiaries had a total liability of 373.1 MB decreased 68.9 MB from December 31, 2017 and

and internal control of subsidiaries improvement. Other Transaction In Quarter 3/2018, the company recorded Baht 4.0 million from gain on changes in fair value less costs to sell biological asset and

operations of Baht 469.53 million, a 20.68% improvement year-over-year from Baht 389.05 million in 9M17. This was mostly due to an increase in revenues from Inpatients, Outpatients and IVF patients. The

assets of consolidated financial statements increased by Baht 63.42 million or 2.19% compared with last year. Most of the increase was from non-current assets in the amount of Baht 104.93 million

) Attributable to Owners of the Company (23.21) (28.30) 5.09 17.99% Non-controlling interests - - - - Total comprehensive income attributable to Owners of the Company (23.21) (28.30) 5.09 17.99% Non-controlling

period (53.94 ) (62.24 ) 8.30 13.34% (44.38%) (56.63%) Basic earnings per share-Owners of the Company (0.06 ) (0.07 ) Attributable to Owners of the Company (53.94) (62.24) 8.30 13.34% Non-controlling

period (53.94 ) (62.24 ) 8.30 13.34% (44.38%) (56.63%) Basic earnings per share-Owners of the Company (0.06 ) (0.07 ) Attributable to Owners of the Company (53.94) (62.24) 8.30 13.34% Non-controlling